GKB Ophthalmics Limited announced key strategic decisions following its Board meeting on November 12, 2026. The company will exit its Unit II plant, transitioning it to a Domestic Tariff Area (DTA) unit. Additionally, the Board approved the sub-leasing of its unutilized building at Plot 16-C&D for an estimated ₹3.85 crore, subject to shareholder approval. These moves are intended to optimize business operations and asset utilization.
Strategic Operational Changes
GKB Ophthalmics Limited’s Board of Directors, in their meeting held on November 12, 2026, decided to exit the company’s Plant at Unit II. This facility, an export-oriented unit located in Tivim Industrial Estate, Mapusa, Goa, will transition to operate as a Domestic Tariff Area (DTA) unit. The decision was based on a review of current business operations, export orders, and market conditions, noting that reduced import duties have diminished previous financial benefits.
Asset Optimization Through Sub-Lease
Further to operational adjustments, the Board also resolved to sub-lease its unutilized building at Plot 16-C&D. This building, constructed at a cost of ₹3.85 crore and situated adjacent to Plot 16-A, has remained vacant since the COVID-19 pandemic. The sub-lease will be executed at prevailing market rates. As the investment for this building exceeds the statutory threshold under Section 180(1)(a) of the Companies Act, 2013, the proposal will be presented to shareholders for approval in due course.
Financial Results Disclosure
The Board also considered and took on record the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. These results, along with their Limited Review Reports, are available on the company’s website and the BSE website.
Source: BSE
